Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Injection Drug Use Part 2: Non-communicable Infections

August 1, 2023
12:00 pm–1:30 pm ET

This training will review strategies to reduce non-communicable infectious diseases in patients that use injection drugs. Safer injection technique, equipment needed for safe injection, and strategies to reduce skin and soft tissue infections (SSTIs) will be discussed. Additional education will be provided about the basics of wound and abscess care for patients to prevent worsening SSTIs.

Register now

Virtual meeting

Via Zoom

Description

This training will review strategies to reduce non-communicable infectious diseases in patients that use injection drugs. Safer injection technique, equipment needed for safe injection, and strategies to reduce skin and soft tissue infections (SSTIs) will be discussed. Additional education will be provided about the basics of wound and abscess care for patients to prevent worsening SSTIs.

The harm reduction series is a 10-part education series for healthcare providers and SUD treatment programs to better understand Harm Reduction principles and harm reduction strategies as best practice in SUD treatment. The series will provide participants with an hour long didactic with a 30 minute Q+A. Each session is taught by an educator from the Grayken TTA team and an expert community member with boots on the ground experience in the specific topic area. Participants may attend all sessions or select specific courses. Continuing education credits are offered for each session.

Intended audience

Medical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community.

Speakers

Habierto (Berto) Sanchez

Heriberto Sanchez is a bilingual public health professional with over 25 years of experience working in the field of addictions. Mr. Sanchez started working with the Boston Public Health Commission, beginning at the AHOPE, providing harm reduction supplies and referrals and transitioning to the City-wide Overdose Prevention Program in 2013. He was one of the lead overdose prevention and Narcan administration trainer in Boston, providing trainings for individuals and organizations on how to respond to an opiate overdose and registering individuals that completed the training as opioid overdose responders. He engages and educates organizations across sectors, including academic settings, healthcare agencies, and the criminal justice system. Prior to becoming the Director of Policy Health and Equity for the city of Boston, Mr. Sanchez worked with outreach, intervention, and advocacy programs addressing issues such as addiction and overdose prevention, harm reduction, street gangs/violence, homelessness, and community re-entry for incarcerated individuals.

Raagini Jawa, MD, MPH, FASAM (she/her)

Dr. Jawa is an Assistant Professor and Clinician Investigator in the Department of General Internal Medicine at University of Pittsburgh Medical Center and a clinician investigator in the Center for Research on Health Care. She is board certified in Internal Medicine and Infectious Disease and Addiction Medicine. Dr. Jawa’s research focuses on the intersection of Infectious Disease and Addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings, developing multidisciplinary provider facing interventions so as to prevent, diagnose, and treat infectious and non-infections complications of drug use. Clinically, she provides office-based addiction treatment in IM Recovery Engagement Program and attends on the Endovascular Infection Service at UPMC.

Objectives

Following this training, participants will have the knowledge necessary to:

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston Medical Center grants 1.50 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of nursing continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.50 general continuing education credits.

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.50 contact hours will be offered to participants who attend the training and complete the evaluation.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2024 Boston Medical Center. All rights reserved. Site by Root802.